Structural insight into human variegate porphyria disease
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Human protoporphyrinogen IX oxidase (hPPO), a mitochondrial inner membrane protein, converts protoporphyrinogen IX to protoporphyrin IX in the heme biosynthetic pathway. Mutations in the hPPO gene cause the inherited human disease variegate porphyria (VP). In this study, we report the crystal structure of hPPO in complex with the coenzyme flavin adenine dinucleotide (FAD) and the inhibitor acifluor‐fen at a resolution of 1.9 Å. The structural and biochemical analyses revealed the molecular details of FAD and acifluorfen binding to hPPO as well as the interactions of the substrate with hPPO. Structural analysis and gel chromatography indicated that hPPO is a monomer rather than a homodimer in vitro. The founder‐effect mutation R59W in VP patients is most likely caused by a severe electrostatic hindrance in the hydrophilic binding pocket involving the bulky, hydro‐phobic indolyl ring of the tryptophan. Forty‐seven VP‐causing mutations were purified by chromatography and kinetically characterized in vitro. The effect of each mutation was demonstrated in the high‐resolution crystal structure.—Qin, X., Tan, Y., Wang, L., Wang, Z., Wang, B., Wen, X., Yang, G., Xi, Z., Shen, Y. Structural insight into human variegate porphyria disease. FASEB J. 25, 653–664 (2011). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biochemistry of heme biosynthesis
Heinemann, I. U., Jahn, M., & Jahn, D. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.015 · Cited by 311
Koch, M., Breithaupt, C., Kiefersauer, R., Freigang, J., Huber, R., & Messerschmidt, A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600189 · Cited by 299 · cited 3×
“The binding mode of FAD with hPPO is similar to that in other reported PPO structures from various species (9, 25, 26).”
BackgroundThe 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis.
(2001) · Nature Structural Biology · doi:10.1038/84152 · Cited by 227
Self-citationTerminal steps of haem biosynthesis
Dailey, H. A. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300590 · Cited by 105
Dailey, T. A., & Dailey, H. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13658 · Cited by 76
Cited by
Dailey, H. A., Gerdes, S., Dailey, T. A., Burch, J. S., & Phillips, J. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416285112 · Cited by 196
“A crystal structure exists for this protein (29), which is of a similar size and structure as the eukaryotic PpoX (30, 31) and Gram-negative HemY (32).”
BackgroundProteomic Mapping of Mitochondria in Living Cells via Spatially Restricted Enzymatic Tagging
Rhee, H.-W., Zou, P., Udeshi, N. D., Martell, J. D., Mootha, V. K., Carr, S. A., & Ting, A. Y. (2013) · Science · doi:10.1126/science.1230593 · Cited by 83
Kobayashi, K., Masuda, T., Tajima, N., Wada, H., & Sato, N. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu170 · Cited by 65
Metadata
- Authors
- Qin, X., Tan, Y., Wang, L., Wang, Z., Wang, B., Wen, X., Yang, G., Xi, Z., & Shen, Y.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2010-11-03
- Volume
- 25
- Issue
- 2
- Pages
- 653-664
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2032884007
- Cited by
- 65
- References
- 5
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural insight into human variegate porphyria disease. https://app.cochat.ai/papers/10.1096/fj.10-170811
- The paper
- Qin, X., Tan, Y., Wang, L., Wang, Z., Wang, B., Wen, X., Yang, G., Xi, Z., & Shen, Y. (2011). Structural insight into human variegate porphyria disease. The FASEB Journal. https://doi.org/10.1096/fj.10-170811
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.